Dr. Anil Kumar Mannava
MD, DNB (Gastroenterology). Consultant Gastroenterologist and Hepatologist
Dr. Anil Kumar Mannava is a consultant gastroenterologist and hepatologist with more than 13 years in medicine. He trained in gastroenterology at Global Hospital, Lakdikapul, and focuses on therapeutic endoscopy, ERCP and endoscopic ultrasound, along with long-term care for liver and pancreatic disease.
- Experience
- 13+ years in medicine
- Medical registration
- No. 66711
- Languages
- Telugu, English, Hindi, Kannada
- Consults at
- Elite Gastro and Liver Clinic, Yella Reddy Guda
Qualifications
DNB (Gastroenterology)
Global Hospital, Lakdikapul, Hyderabad
MD (General Medicine)
Sri Devaraj Urs Medical College, Kolar, Karnataka
MBBS
Dr. Pinnamaneni Siddhartha Institute of Medical Sciences & Research Foundation, Vijayawada (NTR University of Health Sciences)
Experience
- 2020 – presentConsultant Gastroenterologist & Hepatologist
- 2019Consultant GastroenterologistGlobal Hospital, Lakdikapul, Hyderabad
- 2015 – 2016Senior Resident, General MedicineKMC, Mangalore
- 2014 – 2015Senior Resident, General MedicineKMC, Manipal
- 2011 – 2014Junior Resident, General MedicineSri Devaraj Urs Medical College, Kolar
Areas of expertise
- Therapeutic endoscopy and colonoscopy
- ERCP and SpyGlass cholangioscopy
- Interventional biliary and pancreatic EUS
- Third-space endoscopy, including POEM
- Endoscopic mucosal resection (EMR) and submucosal dissection (ESD)
- Endoscopic bariatric procedures
- Clinical research in gastroenterology and hepatology
Advanced procedures: ERCP, Endoscopic ultrasound (EUS), SpyGlass cholangioscopy, POEM for achalasia, EMR and ESD.
Research and clinical trials
He has worked as a principal investigator in gastrointestinal studies and on randomised clinical trials of hepatitis B, hepatitis C and NASH treatments, and has written chapters on acute liver failure and renal dysfunction in chronic liver disease.
Selected publications and presentations
Acute Liver Failure
Clinical Gastroenterology, 4th ed., Paras Medical Publisher, 2020
Renal Dysfunction in Chronic Liver Disease
Clinical Gastroenterology, 4th ed., Paras Medical Publisher, 2020
SNPs in PNPLA3, APOC3 and TM6SF2 genes in NAFLD
Presented at APDW, Kolkata, 2019
Beta Blockers in Cirrhosis of Liver
Gastroenterology Update, Indian Society of Gastroenterology, 2018
Management of a Patient Waitlisted for Liver Transplant
ISGCON Yearbook, 2017
Correlation of Insulin Resistance and Dyslipidemia in NAFLD
Presented at KRSSDI, Belgaum, 2014
Prevalence of Functional Dyspepsia in a Rural Medical College Hospital
Journal of Evolution of Medical and Dental Sciences, 2014
Jaundice Evaluation in Medical Wards
Journal of Biological and Scientific Opinion, 2014
Clinical trials
- Phase 3: Sofosbuvir/Velpatasvir in chronic hepatitis C (GS-US-342-1521)
- Phase 3: Tenofovir alafenamide vs TDF in chronic hepatitis B (GS-US-320-0110)
- Phase 3: Selonsertib in NASH with bridging fibrosis (GS-US-384-1943)
- Phase 3: Selonsertib in compensated cirrhosis due to NASH (GS-US-384-1944)
- Phase 4: Sofosbuvir/Daclatasvir in genotype 3 hepatitis C (MYL-MHD-4001)
- Post-marketing: Sofosbuvir-based regimens in hepatitis C (GS-US-334-1775)
Book a consultation with Dr. Mannava
Consultations in Telugu, English, Hindi and Kannada. No referral needed.